Compared with low SMOC1 expression, high expression level of SMOC1 was correlated with better prognosis in brain glioma [overall survival (OS), HR = 0.55, 95% CIs, 0.4–0.75, Cox p-value = 0.0001], breast cancer, and ovarian cancer. This evidence concerns the gene SMOC1 and breast carcinoma.